SMi is delighted to announce the 4th annual Peptides conference returning to London in 2017!
In the past few years, new technological advancements in the pharma industry have influenced the growth of the global peptide therapeutics market, which is now estimated to reach US $23.70 billion by 2020, with an increased number of peptides now in the pipeline of many biotech companies.
Peptide manufacturers and suppliers have been developing and implementing new technologies to improve the peptide production, reduce manufacturing costs, and allow for more accurate formulations to enhance overall drug delivery. In addition, as cancer has been the most prominent sector in peptide therapeutics and is further expected to stay at the top, the market has been largely driven by the increased demand for peptides in cancer treatment. The increase in collaborations between biotech companies has also contributed to the market growing at this rate.
SMi’s 4th annual Peptides conference will give you the perfect platform to network, collaborate and learn over 2 days, featuring various key presentations by senior level industry professionals. With topics such as peptide formulation and delivery, as well as new advances in alternative peptide analysis technologies, Cell Penetrating Peptides, enhancements in synthesis mechanisms, analytical monitoring techniques, and many more.
You will have the opportunity to gather valuable new insight on assessing biophysical characterization, extending half-life, new formulations and routes of administration, and other pressing matters in the peptides industry.
Venue: Holiday Inn Kensington Forum
Location: 97 Cromwell Rd, London
Country: United Kingdom
Organiser Contact Details:
T: +442078276000 firstname.lastname@example.org